• Japanese
  • Korean
  • Chinese
Cover Image

China Animal Vaccine Industry Report, 2012-2015

Abstract

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.

In 2004-2012, China's animal vaccine market size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth rate of 15% or so, to RMB 15.9 billion in 2016.

China Animal Vaccine Market Size, 2000-2012

Source: Ministry of Agriculture, China Veterinary Drug Association,
ResearchInChina
China Animal Vaccine Industry Report, 2012-2015

Chinese animal vaccine products include swine vaccine, poultry vaccine, cattle & sheep vaccine, pet and other vaccines. As pig and poultry breeding is the core of China's animal husbandry, swine and poultry vaccines account for more than 85% of China's animal vaccine market. In addition, the emerging pet industry is boosting vigorous growth in demand for pet vaccine, while there are few commercial pet vaccines from Chinese animal vaccine companies, mainly dependent on imported products with stiff prices. In future, the Chinese pet vaccine market will usher in large room for promotion.

In 2006, China carried out compulsory veterinary drug GMP certification, raised the industry access threshold, which brought a substantial decline in the number of animal vaccine enterprises, accompanied by increased industry concentration. In 2012, among domestic leading animal vaccine enterprises, China Animal Husbandry Industry Co., Ltd. made the highest animal vaccine revenue of RMB 1.17 billion, with market occupancy up to 12.9%; followed by Qingdao Yebio Bioengineering Co., Ltd (Zhejiang Shenghua Biok Biology Co., Ltd holds 38% stake), Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd., Inner Mongolia Jinyu Group Stock Company, etc..

The Chinese animal vaccine market can be divided into two segments, i.e. government-procured compulsory immunization vaccines and market-oriented vaccines. Currently, there are merely five kinds of compulsory immunization vaccines, and more vaccines are market-oriented. However, in China, compulsory immunization vaccines still hold a market share of over 50%, with highly fierce competition but limited growth potential; by contrast, market-oriented vaccines will enjoy a larger space for development no matter in new product development or in animal protection improvement.

China Animal Vaccine Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:

  • Market size, market structure, competition pattern, etc. of global animal vaccine industry;
  • Market size, market structure, competition pattern, import & export, etc. of China animal vaccine industry;
  • Policy environment, social environment, downstream demand, etc. of China animal vaccine industry;
  • Scale & structure prediction for China animal vaccine market and market segments;
  • Operation, animal vaccine business, forecast & outlook, etc. of 10 animal vaccine producers in China.

STUDY GOAL AND OBJECTIVES

This report provides the industry executives with strategically significant competitor information, analysis, insight and projection on the competitive pattern and key companies in the industry, crucial to the development and implementation of effective business, marketing and R&D programs.

REPORT OBJECTIVES

  • To establish a comprehensive, factual, annually updated and cost-effective information base on market size, competition patterns, market segments, goals and strategies of the leading players in the market, reviews and forecasts.
  • To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
  • To complement the organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
  • To suggest for concerned investors in line with the current development of this industry as well as the development tendency.
  • To help company to succeed in a competitive market, and understand the size and growth rate of any opportunity.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on this industry was conducted. These sources included related books and journals, trade literature, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. Subsequently, telephone interviews or email correspondence was conducted with marketing executives etc. Other sources included related magazines, academics, and consulting companies.

INFORMATION SOURCES

The primary information sources include Company Reports, and National Bureau of Statistics of China etc.

Table of Contents

1. Overview of Animal Vaccine Industry

  • 1.1. Definition
  • 1.2. Classification
  • 1.3. Industry Chain

2. Development Status of Animal Vaccine Industry

  • 2.1. Status of International Animal Vaccine Industry
    • 2.1.1. Market Size
    • 2.1.2. Market Structure
    • 2.1.3. Competition Pattern
    • 2.1.4. New Diseases and New Products
  • 2.2. Status of China Animal Vaccine Industry
    • 2.2.1. Market Size
    • 2.2.2. Market Structure
    • 2.2.3. Import & Export
    • 2.2.4. Profit Level
    • 2.2.5. Entry Barriers
    • 2.2.6. Competition Pattern

3. Development Environment of China Animal Vaccine Industry

  • 3.1. Policy Environment
    • 3.1.1. Major Policies
    • 3.1.2. Compulsory Immunization Vaccine Tender System
  • 3.2. Social Environment
    • 3.2.1. Breeding Industry is Developing Steadily
    • 3.2.2. Large-scale Breeding Becomes a Trend
    • 3.2.3. Animal Epidemics Occur Frequently

4. Development Forecast of China Animal Vaccine Industry

  • 4.1. Overall Forecast
  • 4.2. Swine Vaccine
    • 4.2.1. Swine Fever Vaccine
    • 4.2.2. FMD Vaccine
    • 4.2.3. PRRS Vaccine
    • 4.2.4. Porcine Circovirus Vaccine
  • 4.3. Poultry Vaccine
  • 4.4. Cattle & Sheep Vaccine
  • 4.5. Pet Vaccine

5. Key Companies in China Animal Vaccine Industry

  • 5.1. China Animal Husbandry Industry Co., Ltd. (CAHIC)
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. Animal Vaccine Business
    • 5.1.6. Forecast & Outlook
  • 5.2. Inner Mongolia Jinyu Group Stock Company
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Revenue Structure
    • 5.2.4. Gross Margin
    • 5.2.5. R&D
    • 5.2.6. Animal Vaccine Business
    • 5.2.7. Forecast & Outlook
  • 5.3. Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
    • 5.3.1. Profile
    • 5.3.2. Operation
    • 5.3.3. Revenue Structure
    • 5.3.4. Gross Margin
    • 5.3.5. R&D
    • 5.3.6. Clients & Suppliers
    • 5.3.7. Animal Vaccine Business
    • 5.3.8. Forecast & Outlook
  • 5.4. Ningbo TECH-BANK Co., Ltd.
    • 5.4.1. Profile
    • 5.4.2. Operation
    • 5.4.3. Revenue Structure
    • 5.4.4. Gross Margin
    • 5.4.5. R&D
    • 5.4.6. Animal Vaccine Business
    • 5.4.7. Forecast & Outlook
  • 5.5. Zhejiang Shenghua Biok Biology Co., Ltd.
    • 5.5.1. Profile
    • 5.5.2. Operation
    • 5.5.3. Revenue Structure
    • 5.5.4. Gross Margin
    • 5.5.5. Clients
    • 5.5.6. Animal Vaccine Business
    • 5.5.7. Forecast & Outlook
  • 5.6. Chengdu Huasun Group Inc. Ltd.
    • 5.6.1. Profile
    • 5.6.2. Operation
    • 5.6.3. Revenue Structure
    • 5.6.4. Gross Margin
    • 5.6.5. Clients & Suppliers
    • 5.6.6. Animal Vaccine Business
  • 5.7. Tianjin Ringpu Bio-technology Co., Ltd.
    • 5.7.1. Profile
    • 5.7.2. Operation
    • 5.7.3. Revenue Structure
    • 5.7.4. Gross Margin
    • 5.7.5. R&D
    • 5.7.6. Animal Vaccine Business
    • 5.7.7. Forecast & Outlook
  • 5.8. Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
    • 5.8.1. Profile
    • 5.8.2. Operation
    • 5.8.3. Revenue Structure
    • 5.8.4. Gross Margin
    • 5.8.5. R&D
    • 5.8.6. Animal Vaccine Business
    • 5.8.7. Forecast & Outlook
  • 5.9. Liaoning Yikang Biological Corporation Limited
    • 5.9.1. Profile
    • 5.9.2. Operation
    • 5.9.3. Revenue Structure
    • 5.9.4. Gross Margin
    • 5.9.5. R&D
    • 5.9.6. Clients & Suppliers
    • 5.9.7. Animal Vaccine Business
  • 5.10. Wuhan Chopper Biology Co., Ltd.
    • 5.10.1. Profile
    • 5.10.2. Operation
    • 5.10.3. Revenue Structure
    • 5.10.4. Gross Margin
    • 5.10.5. R&D
    • 5.10.6. Clients & Suppliers
    • 5.10.7. Animal Vaccine Business

Selected Charts:

  • Animal Health Product Classification
  • Animal Vaccine Types (by Constituent and Property) and Features
  • Animal Vaccine Industry Chain
  • China Animal Disease Classification
  • Global Animal Vaccine Market Size, 2008-2016E
  • Basic Information of Global Animal Health Product Industry Giants
  • Foreign Commercial Vaccines and Producers Over the Years
  • China Animal Vaccine Market Size, 2000-2012
  • China Animal Vaccine Product Structure by Animal Attribute, 2008-2012
  • China Animal Vaccine Market Structure by Sales Method
  • Compulsory Immunization Vaccine Product Producers in China, 2012
  • China Commercial Vaccine Classification and Market Situation
  • Import / Export Volume of Veterinary Vaccine in China, 2008-2013
  • Average Import / Export Price of Veterinary Vaccine in China, 2008-2013
  • China Veterinary Vaccine Import Countries by Import Volume, 2012
  • China Veterinary Vaccine Export Destination Distribution by Export Volume, 2012
  • China Veterinary Vaccine Import Areas and % of Import Volume, 2012
  • China Veterinary Vaccine Export Areas and % of Export Volume, 2012
  • Gross Margin of Animal Vaccine Business of Leading Animal Vaccine Listed Companies in China, 2011-2012
  • Barriers to Enter China Animal Vaccine Industry
  • Main Products of Leading Animal Vaccine Producers in China, 2012
  • Revenue of Animal Vaccine Business of Major Animal Vaccine Listed Companies in China, 2011-2012
  • Major Gaps between Chinese Vaccine Production Technology Level and International Advanced Level
  • Sino-foreign Animal Vaccine Joint Ventures, 1990-2012
  • Major Policies on Animal Vaccine Industry in China, 2010-2013
  • National Animal Disease Compulsory Immunization Program in 2013
  • Animal Diseases with Priority to Prevention and Cure in China, 2013-2020
  • Defects of China's Compulsory Immunization Tender System
  • Direction for China's Compulsory Immunization Tender System Reform
  • Meat, Eggs and Milk Output in China, 2008-2012
  • Per Capita Consumption of Pork, Beef and Mutton in China, 2008-2012
  • China Meat Product Structure by Output, 2010-2012
  • Level of Large-scale Breeding in China, 2010-2020
  • Epidemic Prevention Costs of Pig Breeding in China, 2008-2012
  • Overview of Common Animal Epidemics in China
  • China Animal Epidemic Summary, 2013
  • China Animal Vaccine Market Size, 2012-2016E
  • China Animal Vaccine Market Structure by Animal Attribute, 2012 vs. 2016E
  • Hog Breeding Stock and Slaughter in China, 2000-2012
  • China Swine Vaccine Market Size, 2012-2016E
  • Performance Comparison of Various Swine Fever Vaccines in China
  • China Poultry Vaccine Market Size, 2012-2016E
  • Newcastle Disease Vaccine Market Capacity and Ringpu Biology's Market Share
  • China Cattle & Sheep Vaccine Market Size, 2012-2016E
  • China's Per Capita GDP by Province/City, 2012
  • China Pet Vaccine Market Size, 2012-2016E
  • China Pet Vaccine Market Supply Companies
  • Revenue and Net Income of CAHIC, 2008-2012
  • Revenue Breakdown of CAHIC by Product, 2010-2012
  • Revenue Structure of CAHIC by Product, 2010-2012
  • Revenue Breakdown of CAHIC by Region, 2010-2012
  • Revenue Structure of CAHIC by Region, 2010-2012
  • Gross Margin of Main Products of CAHIC, 2010-2012
  • Animal Vaccine Capacity Layout of CAHIC
  • Animal Vaccine Projects under Construction of CAHIC, 2013
  • Revenue and Net Income of CAHIC, 2011-2015E
  • Revenue and Net Income of Jinyu Group, 2008-2012
  • Revenue Breakdown of Jinyu Group by Product, 2010-2012
  • Revenue Structure of Jinyu Group by Product, 2010-2012
  • Revenue Breakdown of Jinyu Group by Region, 2010-2012
  • Revenue Structure of Jinyu Group by Region, 2010-2012
  • Gross Margin of Main Business of Jinyu Group, 2010-2012
  • R&D Costs and % of Total Revenue of Jinyu Group, 2010-2012
  • Animal Vaccine-related Subsidiaries of Jinyu Group, 2012
  • Revenue and Net Income of Jinyu Group, 2011-2015E
  • Revenue and Net Income of Tecon, 2008-2012
  • Revenue Breakdown of Tecon by Product, 2010-2012
  • Revenue Structure of Tecon by Product, 2010-2012
  • Revenue Breakdown of Tecon by Region, 2010-2012
  • Revenue Structure of Tecon by Region, 2010-2012
  • Gross Margin of Main Products of Tecon, 2010-2012
  • R&D Costs and % of Total Revenue of Tecon, 2010-2012
  • Tecon's Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
  • Name List and Revenue Contribution of Tecon's Top 5 Clients, 2012
  • Tecon's Procurement from Top 5 Suppliers and % of Total Procurement, 2012
  • Progress of Animal Vaccine R&D Projects of Tecon, 2012
  • Revenue and Net Income of Tecon, 2011-2015E
  • Revenue and Net Income of TECH-BANK, 2008-2012
  • Revenue Breakdown of TECH-BANK by Product, 2010-2012
  • Revenue Structure of TECH-BANK by Product, 2010-2012
  • Revenue Breakdown of TECH-BANK by Region, 2010-2012
  • Revenue Structure of TECH-BANK by Region, 2010-2012
  • Gross Margin of Main Products of TECH-BANK, 2010-2012
  • R&D Costs and % of Total Revenue of TECH-BANK, 2010-2012
  • Revenue and Net Income of Chengdu TECBOND Biological Products, 2010-2012
  • Revenue and Net Income of TECH-BANK, 2011-2015E
  • Revenue and Net Income of Shenghua Biok, 2008-2012
  • Revenue Breakdown of Shenghua Biok by Product, 2010-2012
  • Revenue Structure of Shenghua Biok by Product, 2010-2012
  • Revenue Breakdown of Shenghua Biok by Region, 2010-2012
  • Revenue Structure of Shenghua Biok by Region, 2010-2012
  • Gross Margin of Main Products of Shenghua Biok, 2010-2012
  • Shenghua Biok's Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
  • Name List and Revenue Contribution of Shenghua Biok's Top 5 Clients, 2012
  • Revenue and Net Income of Qingdao Yebio Bioengineering, 2008-2012
  • Revenue and Net Income of Shenghua Biok, 2011-2015E
  • Revenue and Net Income of Huasun Group, 2008-2012
  • Revenue Breakdown of Huasun Group by Product, 2010-2012
  • Revenue Structure of Huasun Group by Product, 2010-2012
  • Revenue Breakdown of Huasun Group by Region, 2010-2012
  • Revenue Structure of Huasun Group by Region, 2010-2012
  • Gross Margin of Main Products of Huasun Group, 2010-2012
  • Huasun Group's Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
  • Name List and Revenue Contribution of Huasun Group's Top 5 Clients, 2012
  • Huasun Group's Procurement from Top 5 Suppliers and % of Total Procurement, 2010-2012
  • Name List and Procurement Contribution of Huasun Group's Top 5 Suppliers, 2012
  • Revenue and Net Income of Ringpu Bio-technology, 2008-2012
  • Revenue Breakdown of Ringpu Bio-technology by Product, 2010-2012
  • Revenue Structure of Ringpu Bio-technology by Product, 2010-2012
  • Revenue Breakdown of Ringpu Bio-technology by Region, 2010-2012
  • Revenue Structure of Ringpu Bio-technology by Region, 2010-2012
  • Gross Margin of Main Products of Ringpu Bio-technology, 2010-2012
  • R&D Costs and % of Total Revenue of Ringpu Bio-technology, 2008-2012
  • Output and Sales Volume of Animal Vaccine Products of Ringpu Bio-technology, 2011-2012
  • Sales and Gross Margin of Animal Vaccine of Ringpu Bio-technology by Product, 2012
  • Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
  • Revenue and Net Income of Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
  • Progress of Animal Vaccine-related Projects of Ringpu Bio-technology, 2012
  • Revenue and Net Income of Ringpu Bio-technology, 2011-2015E
  • Revenue and Net Income of Dahuanong, 2008-2012
  • Revenue Breakdown of Dahuanong by Product, 2010-2012
  • Revenue Structure of Dahuanong by Product, 2010-2012
  • Revenue Breakdown of Dahuanong by Region, 2010-2012
  • Revenue Structure of Dahuanong by Region, 2010-2012
  • Gross Margin of Main Products of Dahuanong, 2010-2012
  • R&D Costs and % of Total Revenue of Dahuanong, 2010-2012
  • Output, Sales Volume and Sales-Output Ratio of Veterinary Biological Products of Dahuanong, 2011-2012
  • Progress of Animal Vaccine-related Projects of Dahuanong by end-2012
  • Revenue and Net Income of Dahuanong, 2011-2015E
  • Revenue and Net Income of Yikang Biological, 2009-2011
  • Revenue Breakdown of Yikang Biological by Product, 2009-2011
  • Revenue Structure of Yikang Biological by Product, 2009-2011
  • Revenue Breakdown of Yikang Biological by Region, 2009-2011
  • Revenue Structure of Yikang Biological by Region, 2009-2011
  • Gross Margin of Main Products of Yikang Biological, 2009-2011
  • R&D Costs and % of Total Revenue of Yikang Biological, 2009-2011
  • Yikang Biological's Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
  • Name List and Revenue Contribution of Yikang Biological's Top 5 Clients, 2011
  • Yikang Biological's Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
  • Name List and Procurement Contribution of Yikang Biological's Suppliers, 2011
  • Animal Vaccine Production Lines of Yikang Biological, 2009-2011
  • Capacity, Output and Capacity Utilization of Yikang Biological, 2009-2011
  • Output, Sales Volume and Sales-Output Ratio of Yikang Biological, 2009-2011
  • Average Sales Price of Main Products of Yikang Biological, 2009-2011
  • Revenue Structure of Yikang Biological by Sales Model, 2009-2011
  • Revenue and Net Income of Chopper Biology, 2009-2011
  • Revenue Breakdown of Chopper Biology by Product, 2009-2011
  • Revenue Structure of Chopper Biology by Product, 2009-2011
  • Revenue Breakdown of Chopper Biology by Region, 2009-2011
  • Revenue Structure of Chopper Biology by Region, 2009-2011
  • Gross Margin of Main Products of Chopper Biology, 2009-2011
  • R&D Costs and % of Total Revenue of Chopper Biology, 2009-2011
  • Chopper Biology's Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
  • Name List and Revenue Contribution of Chopper Biology's Top 5 Clients, 2011
  • Sales Contract between Chopper Biology and Animal Husbandry and Veterinary Bureau of Hubei Province, 2011
  • Chopper Biology's Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
  • Name List and Procurement Contribution of Chopper Biology's Suppliers, 2011
  • Sales of Major Vaccine Products of Chopper Biology, 2009-2011
  • Vaccine Capacity, Output and Capacity Utilization of Chopper Biology, 2009-2011
  • Vaccine Output, Sales Volume and Sales-Output Ratio of Chopper Biology, 2009-2011
  • Average Sales Price of Major Vaccine Products of Chopper Biology, 2009-2011
  • Investment Plan of Chopper Biology, 2012
Show More
Pricing
Get Notified
Email me when related reports are published